Depletion of the nucleolar protein nucleostemin causes G1 cell cycle arrest via the p53 pathway

Molecular Biology of the Cell

Volumn 18, Issue 7, 2007, Pages 2630-2635

  Ma, Hanhui ^a   Pederson, Thoru ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NUCLEAR PROTEIN; NUCLEOSTEMIN; PROTEIN P14ARF; PROTEIN P53; RETINOBLASTOMA PROTEIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ARTICLE; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CONTROLLED STUDY; DOWN REGULATION; GROWTH REGULATION; HELA CELL; HUMAN; HUMAN CELL; NUCLEOLUS; OSTEOSARCOMA CELL; PRIORITY JOURNAL; RNA INTERFERENCE;

ADP-RIBOSYLATION FACTORS; CARRIER PROTEINS; CELL NUCLEOLUS; DOWN-REGULATION; G1 PHASE; HELA CELLS; HUMANS; NUCLEAR PROTEINS; PROTO-ONCOGENE PROTEINS C-MDM2; RETINOBLASTOMA PROTEIN; TUMOR SUPPRESSOR PROTEIN P53; UP-REGULATION;

EID: 34347376389     PISSN: 10591524     EISSN: None     Source Type: Journal    
DOI: 10.1091/mbc.E07-03-0244     Document Type: Article

References (29)

1. Baddoo, M., Hill, K., Wilkinson, R., Gaupp, D., Hughes, C., Kopen, G. C., and Phinney, D. G. (2003). Characterization of mesenchymal stem cells isolated from murine bone marrow by negative selection. J. Cell. Biochem. 89, 1235-1249.
2. Beekman, C., Nichane, M., De Clercq, S., Maetens, M., Floss, T., Wurst, W., Bellefroid, E., and Marine, J.-C. (2006). Evolutionarily conserved role of nucleostemin controlling proliferation of stem/progenitor cells during early vertebrate development. Mol. Cell. Biol. 26, 9291-9301.
3. Bensaad, K., and Vousden, K. H. (2005). Savior and slayer: the two faces of p53. Nat. Med. 11, 1278-1279.
4. Bernardi, R., Scaglioni, P. P., Bergmann, S., Horn, H. F., Vousden, K. H., and Pandolfi, P. P. (2004). PML regulates p53 stability by sequestering Mdm2 to the nucleolus. Nat. Cell Biol. 6, 665-672.
5. Blander, G., Kipnis, J., Leal, J.F.M., Yu, C.-E., Schellenberg, G. D., and Oren, M. (1999). Physical and functional interaction between p53 and the Werner's syndrome protein. J. Biol. Chem. 274, 29463-29469.
6. Campbell, R. E., Tour, O., Palmer, A. E., Steinbach, P. A., Baird, G. S., Zacharias, D. A., and Tsien, R. Y. (2002). A monomeric red fluorescent protein. Proc. Natl. Acad. Sci. USA 99, 7877-7882.
7. Colombo, E., Marine, J. C., Danovi, D., Faltai, B., and Pelicci, P. G. (2002). Nucleophosmin regulates the stability and transcriptional activity of p53. Nat. Cell. Biol. 4, 529-533.
8. Dai, M. S., and Lu, H. (2004). Inhibition of MDM2-mediated p53 ubiquitination and ribosomal protein L5. J. Biol. Chem. 279, 44475-44482.
9. Daniely, Y., Dimitrova, D. D., and Borowiec, J. A. (2002). Stress-dependent nucleolin mobilization mediated by p53-nucleolta complex formation. Mol. Cell. Biol. 22, 6014-6022.
10. Haupt, Y., Maya, R., Kazaz, A., and Oren, M. (1997). Mdm2 promotes the rapid degradation of p53. Nature 387, 296-299.
11. Horn, H. F., and Vousden, K. H. (2004). Guarding the guardian? Nature 427, 110-111.
12. Jin, A., Itahana, K., O'Keefe, K., and Zhang, Y. (2004). Inhibition of HDM2 and activation of p53 by ribosomal protein L23. Mol. Cell. Biol. 24, 7669-7680.
13. Kubbutat, M. H., Jones, S. N., and Vousden, K. H. (1997). Regulation of p53 stability by Mdm2. Nature 387, 299-303.
14. Liu, S. J., Cai, Z. W., Liu, Y. J., Dong, M. Y., Sun, L. Q., Hu, G. F., Wei, Y. Y., and Lao, W. D. (2004). Role of nucleostemin in growth regulation of gastric, liver cancer and other malignancies. World J. Gastroenterol. 10, 1246-1249.
15. Lohrum, M. A., Ludwig, R. L., Kubbutat, M. H., Hanlon, M., and Vousden, K. H. (2003). Regulation of HDM2 activity by the ribosomal protein L11. Cancer Cell 3, 577-578.
16. Pederson, T. (1999). Growth factors in the nucleolus? J. Cell Biol. 143, 279-281.
17. Pestov, D. G., Strezoska, Z., and Lau, L. F. (2001). Evidence of p53-dependent cross-talk between ribosome biogenesis and the cell cycle: effects of nucleolar protein Bop1 on G(1)/S transition. Mol. Cell. Biol. 21, 4246-4255.
18. Politz, J.C.R., Polena, I., Trask, I., Bazett-Jones, D. P., and Pederson, T. (2005). A nonribosomal landscape in the nucleolus revealed by the stem cell protein nucleostemin. Mol. Biol. Cell 16, 3401-3410.
19. Raska, I., Shaw, P. J., and Cmarko, D. (2006). New insights into nucleolar architecture and activity. Intl. Rev. Cytol. 255, 177-235.
20. Rubbi, C. P., and Milner, J. (2003). Disruption of the nucleolus mediates stabilization of p53 in response to DNA damage and other stresses. EMBO J. 22, 6068-6077.
21. ARF, participates in a regulatory feedback loop with p53 and MDM2. EMBO J. 17, 5001-5015.
22. Sulic, S., Panic, L., Barkic, M., Mercep, M., Uzelac, M., and Volarevic, S. (2005). Inactivation of S6 ribosomal protein gene in T lymphocytes activates a p53-dependent checkpoint response. Genes Dev. 19, 3070-3082.
23. Takagi, M., Absalon, M., McLure, K. G., and Kastan, M. B. (2005). Regulation of p53 translation and induction after DNA damage by ribosomal protein L26 and nucleolin. Cell 123, 49-63.
24. Tsai, R.Y.L., and McKay, R.D.G. (2002). A nucleolar mechanism controlling cell proliferation in stem cells and cancer cells. Genes Dev. 16, 2991-3003.
25. Tsai, R.Y.L., and McKay, R.D.G. (2005). A multistep, GTP-driven mechanism controlling the dynamic cycling of nucleostemin. J. Cell Biol. 168, 179-184.
26. Vogelsteta, B., Lane, D., and Levine, A. J. (2000). Surfing the p53 network. Nature 408, 307-310.
27. Vousden, K. H. (2006). Outcomes of p53 activation-spoilt for choice. J. Cell Sci. 199, 5015-5020.
28. Yuan, X., Zhou, Y., Casanova, E., Chai, M., Kiss, E., Gröne, H.-J., Schütz, G., and Grummt, I. (2005). Genetic inactivation of the transcription factor TIF-1A leads to nucleolar disruption, cell cycle arrest, and p53-mediated apoptosis. Mol. Cell 19, 77-87.
29. Zhu, Q., Yasumoto, H., and Tsai, R.Y.L. (2006). Nucleostemin delays cellular senescence and negatively regulates TRF1 protein stability. Mol. Cell. Biol. 26, 9279-9290.